TD Cowen analyst Derrick Wood raised the firm’s price target on Confluent (CFLT) to $37 from $31 and keeps a Buy rating on the shares. The firm ...

Besides Wall Street's top -and-bottom-line estimates for Confluent (CFLT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...

Confluent’s financial performance doesn’t match its premium pricing. Learn why CFLT stock is risky given its minimal ...

Scotiabank analyst Nick Altmann maintained a Hold rating on Confluent (CFLT – Research Report) today and set a price target of $27.00. The ...

Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

TD Cowen analysts showed continued confidence in Confluent Inc (NASDAQ:CFLT), raising the company's price target from $31.00 to $37.00 while maintaining a Buy rating. The adjustment comes ahead of ...

In the last three months, 11 analysts have published ratings on Confluent (NASDAQ:CFLT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...

Confluent (NASDAQ:CFLT – Free Report) had its price objective hoisted by Guggenheim from $32.00 to $35.00 in a research note released on Friday morning,Benzinga reports. Guggenheim currently has a buy ...

Confluent is a terrific "growth at a reasonable price" software stock that has only seen its share price rise ~20% over the past year, despite strong growth. Confluent, founded by creators of open ...

Detailed price information for Confluent Inc Cl A (CFLT-Q) from The Globe and Mail including charting and trades.